arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Neurocrine Biosciences, Inc.

NBIX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$163.88
▼ -2.1% Today
as of Jun 7, 07:22 ET
Last 30 days +27.91% Apr 28 → Jun 05
$124.98 $136.36 $147.74 $159.11 $170.49 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$167.53
High
$168.00
Low
$163.11
Volume
$1M
Avg Vol
$1M
Mkt Cap
$15.7B
P/E (TTM)
32.71
Beta
52w High
$168.00
52w Low
$122.14
Div Yield
Shares Out
$101M

Overview

52-week range
$122
$168
91% of range
Avg surprise (last 2)
-35.6%
Avg reaction (last 2)
+0.4%
100% positive
Latest IV / EM
44%
EM ±6.1% · $165 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.08$0.57$1.06$1.55$2.04 Actual $0.95Actual $0.82Actual $0.42Actual $0.63Actual $1.24Actual $0.08Est $0.43Actual $1.06Actual $2.04Actual $1.41Est $1.28 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$0$55M$110M$165M$220M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $1.41 $1.28 +10.2% +1,662% +0.7% earnings
Tue Sep 30, 2025Sep 2025 $2.04 financials
Mon Jun 30, 2025Jun 2025 $1.06 financials
Mon May 5, 2025Mar/2025 $0.08 $0.43 -81.4% +0.1% earnings
Mon Sep 30, 2024Sep 2024 $1.24 financials
Sun Jun 30, 2024Jun 2024 $0.63 financials
Sun Mar 31, 2024Mar 2024 $0.42 financials
Sat Sep 30, 2023Sep 2023 $0.82 financials
Fri Jun 30, 2023Jun 2023 $0.95 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$14M$14M$11M$9M$8M$9M
Gross profit
Operating income$193M$239M$146M$24M$184M$145M
Net income$198M$210M$108M$8M$130M$65M
EPS (diluted)$1.91$2.04$1.06$0.08$1.24$0.63

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$266M$713M$340M$264M$194M$233M$349M$140M
Inventory$64M$69M$69M$57M$59M$57M$46M$42M
Total current assets$2.44B$2.52B$2.16B$1.75B$1.64B$1.72B$1.88B$1.67B
Total assets$4.91B$4.63B$4.27B$3.89B$3.69B$3.72B$3.54B$3.31B
Long-term debt
Total liabilities$1.50B$1.38B$1.26B$1.20B$1.15B$1.13B$816M$796M
Total equity$3.41B$3.25B$3.00B$2.69B$2.54B$2.59B$2.72B$2.51B

Implied volatility — last 90 days

38%41%43%46%48% Jun 07 — IV 44% · EM ±6.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.